These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19740327)

  • 21. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
    Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
    Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis.
    Kozono Y; Duke RC; Schleicher MS; Holers VM
    Eur J Immunol; 1995 Apr; 25(4):1013-7. PubMed ID: 7737272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
    Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
    J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
    Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
    Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
    Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors.
    Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E
    J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD21 signaling via C3 regulates Purkinje cell protein 4 expression.
    Jacobson AC; Weis JJ; Weis JH
    Mol Immunol; 2009 Apr; 46(7):1488-93. PubMed ID: 19201479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K; Sher A; Gaither T; Hammer C
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.
    Neher MD; Rich MC; Keene CN; Weckbach S; Bolden AL; Losacco JT; Patane J; Flierl MA; Kulik L; Holers VM; Stahel PF
    J Neuroinflammation; 2014 May; 11():95. PubMed ID: 24885042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of complement receptors 1 and 2 on mouse splenic B cells using flow cytometry.
    Donius LR; Weis JH
    Methods Mol Biol; 2014; 1100():305-10. PubMed ID: 24218269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
    Wilson JG; Ratnoff WD; Schur PH; Fearon DT
    Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).
    Micklem KJ; Sim RB; Sim E
    Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.
    Delibrias CC; Kazatchkine MD; Fischer E
    Scand J Immunol; 1993 Aug; 38(2):183-9. PubMed ID: 8346417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligands of CR2 do not interfere with C3 fragment fixation or enhanced NK sensitivity of Raji cells treated with human serum.
    Yefenof E; Ramos OF; Nilsson B; Klein E
    Immunol Lett; 1989 Jun; 21(4):303-6. PubMed ID: 2527817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.
    Carter RH; Spycher MO; Ng YC; Hoffman R; Fearon DT
    J Immunol; 1988 Jul; 141(2):457-63. PubMed ID: 2968402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
    Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
    Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.